Dr. Ramy Said Goueli, MD

Dr. Goueli practices at UT Southwestern Medical Group in Dallas, Texas.

Dr. Goueli's NPI, 1699118687, was assigned on April 10, 2013. Dr. Goueli graduated from Yale School of Medicine in 2012. Dr. Goueli holds Texas license S3906.

Dr. Goueli's primary practice is UT Southwestern Medical Group, at 2001 Inwood Rd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 645-0624.

Dr. Goueli's primary practice is UT Southwestern Medical Group in Dallas, Texas. Dr. Goueli is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Goueli to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goueli practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Goueli's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Goueli is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dr. Goueli is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Dr. Goueli treats.

CMS data shows 4,579 Medicare services from Dr. Goueli across 18 procedure codes in 2024, for 422 Medicare patients. Medicare paid $92,864 for them.

CMS counts 422 Medicare patients who saw Dr. Goueli in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goueli's median patient age at 69, with 26% women.

In 2024, Dr. Goueli wrote 880 Medicare Part D claims for 270 patients. 89% of them were for generic drugs. CMS names the drug for 775 of them, across 18 drugs with 11 or more claims each, at $73,351 in total drug cost. In 2023, CMS named 575 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Goueli for performance year 2024, reported as part of a group. Dr. Goueli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goueli as offering telehealth. CMS counts 42 procedures of prostate resection by Dr. Goueli, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Goueli, published from 2017 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Pelvic Organ Prolapse, Prostate and Prostatic Hyperplasia. Dr. Goueli has published most often in Urology. Dr. Goueli's most frequent co-authors are Maude Carmel, FRCSC, MD, Gary Evan Lemack, MD and Philippe E. Zimmern, MD.

CMS Open Payments shows 50 general payments to Dr. Goueli from 12 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 98% of the total. Medtronic, Inc. paid the most, $1,780.

Dr. Goueli graduated from Yale School of Medicine in 2012.

Dr. Goueli is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.